• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
The influence of diabetes and hypertension on outcome in COVID-19 patients: Do we mix apples and oranges?糖尿病和高血压对COVID-19患者预后的影响：我们是在将苹果与橙子混为一谈吗？
J Clin Hypertens (Greenwich). 2021 Feb;23(2):235-237. doi: 10.1111/jch.14145. Epub 2020 Dec 25.
2
Is hypertension without any other comorbidities an independent predictor for COVID-19 severity and mortality?无其他合并症的高血压是新冠病毒疾病严重程度和死亡率的独立预测因素吗？
J Clin Hypertens (Greenwich). 2021 Feb;23(2):232-234. doi: 10.1111/jch.14144. Epub 2020 Dec 23.
3
Utilizing Mobile Health Units for Mass Hypertension Screening in Socially Vulnerable Communities Across Detroit.利用移动医疗单位在底特律社会弱势群体社区进行大规模高血压筛查。
Hypertension. 2022 Jun;79(6):e106-e108. doi: 10.1161/HYPERTENSIONAHA.122.19088. Epub 2022 Mar 16.
4
[Diabetes and hypertension as factors associated with Covid-19 lethality in Sonora, Mexico, 2020].[2020年，糖尿病和高血压作为墨西哥索诺拉州与新冠病毒致死率相关的因素]
Salud Publica Mex. 2020 Sep-Oct;62(5):456-457. doi: 10.21149/11546.
5
Characteristics of COVID-19 at a non-COVID tertiary pulmonary care centre in Delhi, India.印度德里一家非新冠三级肺病护理中心的新冠病毒病特征
Monaldi Arch Chest Dis. 2020 Nov 9;90(4). doi: 10.4081/monaldi.2020.1568.
6
Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.墨西哥门诊和住院患者严重急性呼吸综合征冠状病毒 2 感染后生存的决定因素。
Public Health. 2020 Dec;189:66-72. doi: 10.1016/j.puhe.2020.09.014. Epub 2020 Sep 30.
7
Prevalence of Systemic Arterial Hypertension and Diabetes Mellitus in Individuals with COVID-19: A Retrospective Study of Deaths in Pernambuco, Brazil.新型冠状病毒肺炎患者中系统性动脉高血压和糖尿病的患病率：巴西伯南布哥州死亡病例的回顾性研究
Arq Bras Cardiol. 2021 Aug;117(2):416-422. doi: 10.36660/abc.20200885.
8
Fangcang shelter hospitals in COVID-19 pandemic: the practice and its significance.新冠疫情期间的方舱医院：实践及其意义
Clin Microbiol Infect. 2020 Aug;26(8):976-978. doi: 10.1016/j.cmi.2020.04.038. Epub 2020 May 1.
9
No adequate evidence indicating hypertension as an independent risk factor for COVID-19 severity.没有充分证据表明高血压是新冠病毒疾病严重程度的独立危险因素。
Clin Res Cardiol. 2021 Jan;110(1):146-147. doi: 10.1007/s00392-020-01653-6. Epub 2020 Apr 23.
10
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.中国武汉 140 名 SARS-CoV-2 感染患者的临床特征。
Allergy. 2020 Jul;75(7):1730-1741. doi: 10.1111/all.14238. Epub 2020 Feb 27.

引用本文的文献

1
Prevalence of Hypertension and Diabetes in Severe COVID-19: A Cross-Sectional Study from Single Center, Kabul [Letter].重症新型冠状病毒肺炎患者中高血压和糖尿病的患病率：来自喀布尔单中心的横断面研究[信函]
Infect Drug Resist. 2024 May 31;17:2225-2226. doi: 10.2147/IDR.S477018. eCollection 2024.
2
Disease Outcomes of COVID-19 in Diabetic and Hypertensive Patients During the Hospital Stay.糖尿病和高血压患者住院期间新冠病毒病的疾病转归
Cureus. 2023 Oct 13;15(10):e46943. doi: 10.7759/cureus.46943. eCollection 2023 Oct.
3
Effects of Hypertension Alone and in Comorbidity with Diabetes on Death within 30 Days among Inpatients with COVID-19 Infection.高血压单独及合并糖尿病对 COVID-19 感染住院患者 30 天内死亡的影响。
J Res Health Sci. 2022 Dec;22(4):e00565. doi: 10.34172/jrhs.2022.100.
4
COVID-19 Viral Infection Presenting With Diabetic Ketoacidosis, Hyperosmolar Hyperglycemic Syndrome, or Mixed Hyperglycemic Crisis: A Case Series.新冠病毒感染伴发糖尿病酮症酸中毒、高渗高血糖综合征或混合性高血糖危象：病例系列
J Community Hosp Intern Med Perspect. 2023 Mar 10;13(2):76-83. doi: 10.55729/2000-9666.1163. eCollection 2023.
5
Factors Affecting Confirmed COVID-19 Patient's Recovery Time at King Abdulaziz Medical City, Jeddah.影响吉达阿卜杜勒阿齐兹国王医疗城新冠肺炎确诊患者康复时间的因素
Cureus. 2023 Jan 24;15(1):e34130. doi: 10.7759/cureus.34130. eCollection 2023 Jan.
6
Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 Patients.新冠病毒肺炎患者的药物-疾病严重程度和靶疾病严重程度相互作用网络
Pharmaceutics. 2022 Aug 30;14(9):1828. doi: 10.3390/pharmaceutics14091828.
7
Diabetic ketoacidosis amongst patients with COVID-19: A retrospective chart review of 220 patients in Pakistan.COVID-19 患者中的糖尿病酮症酸中毒：巴基斯坦 220 例患者的回顾性图表分析。
Endocrinol Diabetes Metab. 2022 May;5(3):e00331. doi: 10.1002/edm2.331. Epub 2022 Feb 24.
8
Severity of coronavirus disease 19: Profile of inflammatory markers and (rs4646994) and (rs2285666) gene polymorphisms in Iraqi patients.新型冠状病毒肺炎的严重程度：伊拉克患者炎症标志物及（rs4646994）和（rs2285666）基因多态性概况
Meta Gene. 2022 Feb;31:101014. doi: 10.1016/j.mgene.2022.101014. Epub 2022 Jan 10.
9
Respiratory Pathophysiology of Mechanically Ventilated COVID-19 Patients.机械通气的新冠病毒肺炎患者的呼吸病理生理学
Cureus. 2021 Dec 6;13(12):e20218. doi: 10.7759/cureus.20218. eCollection 2021 Dec.

本文引用的文献

1
Independent and combined effects of hypertension and diabetes on clinical outcomes in patients with COVID-19: A retrospective cohort study of Huoshen Mountain Hospital and Guanggu Fangcang Shelter Hospital.高血压和糖尿病对 COVID-19 患者临床结局的独立和联合影响：火神山医院和光谷方舱医院的回顾性队列研究。
J Clin Hypertens (Greenwich). 2021 Feb;23(2):218-231. doi: 10.1111/jch.14146. Epub 2020 Dec 25.
2
Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study.2 型糖尿病患者因 COVID-19 住院与降糖药物相关的死亡率和其他不良结局：一项全国性队列研究。
BMC Med. 2020 Nov 16;18(1):359. doi: 10.1186/s12916-020-01832-2.
3
Predictors of mortality in patients with COVID-19-a systematic review.新型冠状病毒肺炎患者死亡的预测因素——一项系统综述
Eur J Integr Med. 2020 Dec;40:101226. doi: 10.1016/j.eujim.2020.101226. Epub 2020 Oct 17.
4
Influence of blood pressure control and application of renin-angiotensin-aldosterone system inhibitors on the outcomes in COVID-19 patients with hypertension.血压控制及肾素-血管紧张素-醛固酮系统抑制剂的应用对合并高血压的 COVID-19 患者结局的影响。
J Clin Hypertens (Greenwich). 2020 Nov;22(11):1974-1983. doi: 10.1111/jch.14038. Epub 2020 Oct 2.
5
Association of Hypertension with All-Cause Mortality among Hospitalized Patients with COVID-19.新冠肺炎住院患者中高血压与全因死亡率的关联
J Clin Med. 2020 Sep 28;9(10):3136. doi: 10.3390/jcm9103136.
6
Prevalence of Diabetes and Hypertension and Their Associated Risks for Poor Outcomes in Covid-19 Patients.2019冠状病毒病患者中糖尿病和高血压的患病率及其不良结局相关风险
J Endocr Soc. 2020 Jul 21;4(9):bvaa102. doi: 10.1210/jendso/bvaa102. eCollection 2020 Sep 1.
7
Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis.糖尿病、高血压和心血管疾病患者中新冠病毒肺炎的严重程度和死亡率：一项荟萃分析。
Diabetol Metab Syndr. 2020 Aug 31;12:75. doi: 10.1186/s13098-020-00586-4. eCollection 2020.
8
Blood pressure control and adverse outcomes of COVID-19 infection in patients with concomitant hypertension in Wuhan, China.中国武汉合并高血压的 COVID-19 感染患者的血压控制与不良结局。
Hypertens Res. 2020 Nov;43(11):1267-1276. doi: 10.1038/s41440-020-00541-w. Epub 2020 Aug 27.
9
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration.新诊断的糖尿病和入院时的高血糖通过加重呼吸恶化预测 COVID-19 的严重程度。
Diabetes Res Clin Pract. 2020 Oct;168:108374. doi: 10.1016/j.diabres.2020.108374. Epub 2020 Aug 15.
10
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study.英格兰 1 型和 2 型糖尿病患者 COVID-19 相关死亡率的风险因素：一项基于人群的队列研究。
Lancet Diabetes Endocrinol. 2020 Oct;8(10):823-833. doi: 10.1016/S2213-8587(20)30271-0. Epub 2020 Aug 13.

The influence of diabetes and hypertension on outcome in COVID-19 patients: Do we mix apples and oranges?

作者信息

Tadic Marijana, Cuspidi Cesare

机构信息

University Hospital "Dr. Dragisa Misovic-Dedinje" Department of Cardiology, Belgrade, Serbia.

University of Milan-Bicocca, Milan, Italy.

出版信息

J Clin Hypertens (Greenwich). 2021 Feb;23(2):235-237. doi: 10.1111/jch.14145. Epub 2020 Dec 25.

DOI:10.1111/jch.14145
PMID:33369012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8029782/
Abstract
摘要